ATO Clears Senetas’ $5.5 Million Capital Distribution Treatment

ATO Confirms Capital Treatment for Two Distributions

Senetas Corporation Limited (ASX:SEN) has secured a tax ruling that removes the main uncertainty around two cash distributions made to shareholders. The Australian Taxation Office has confirmed that payments totalling approximately $5.5 million will be treated as returns of capital, rather than dividends, for eligible Australian-resident shareholders.

The ruling covers the $0.00120772 per share Distribution 1, approved in November 2025 and paid on 27 November, and the much larger $0.2111 per share Distribution 2, approved in July 2026 and paid on 7 August. The second payment formed part of the $3.5 million capital return completed by Senetas in August.

Withheld Tax Payments to Be Returned

Where tax was withheld from the capital-return payments, Senetas said those amounts will be paid back to shareholders within the next 14 days. The company’s earlier proposal had left the tax treatment under review, making the ATO confirmation a useful resolution for affected holders.

For Australian residents who held the shares on the relevant record dates and received the distributions, the payments will not be treated as dividends for income-tax purposes. Instead, each payment generally reduces the cost base and reduced cost base of the relevant shares. That can increase a future capital gain when the shares are sold.

Cost Base Rules Still Matter

If the distributions exceed a shareholder’s cost base, the cost base falls to nil and the excess becomes a capital gain. The practical outcome will therefore depend on each investor’s original purchase price, holding period and broader tax position, rather than simply on the amount distributed.

The ruling does not apply to non-resident shareholders, investors holding shares on revenue account or as trading stock, or taxpayers subject to the taxation of financial arrangements rules. The final ruling is still to be published in its final form, although Senetas said the ATO has confirmed the treatment and will record it as a notifiable instrument.